Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
EMBO Molecular Medicine|March 20, 2023
Quantitative protein biomarker panels: a path to improved clinical practice through proteomicsJohannes Hartl, Florian Kurth, Kai Kappert, et al.
Histopathology|January 27, 2012
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancerJens Neumann, David Horst, Lydia Kriegl, et al.
American Journal of Cancer Research|September 2, 2015
ITF-2B protein levels are correlated with favorable prognosis in patients with colorectal carcinomasLydia Brandl, David Horst, Enrico de Toni, et al.
The Journal of Pathology|July 22, 2009
The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancerDavid Horst, Silvio K Scheel, Sibylle Liebmann, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinomaMarkus Reschke, Ingvar Ferby, Ewa Stepniak, et al.
Cancer Research|February 17, 2017
Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS MutationsCristina Blaj, Eva Marina Schmidt, Sebastian Lamprecht, et al.
Nature Communications|November 12, 2017
Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancerSebastian Lamprecht, Eva Marina Schmidt, Cristina Blaj, et al.
Gastroenterology|August 13, 2018
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1Meryem Gülfem Öner, Matjaz Rokavec, Markus Kaller, et al.
BMC Cancer|November 3, 2019
Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapyIryna Trotsyuk, Halina Sparschuh, Alice Josephine Müller, et al.
Experimental and Molecular Pathology|November 22, 2011
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumorsTobias Vogler, Lydia Kriegl, David Horst, et al.
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
EMBO Molecular Medicine|March 20, 2023
Quantitative protein biomarker panels: a path to improved clinical practice through proteomicsJohannes Hartl, Florian Kurth, Kai Kappert, et al.
Histopathology|January 27, 2012
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancerJens Neumann, David Horst, Lydia Kriegl, et al.
American Journal of Cancer Research|September 2, 2015
ITF-2B protein levels are correlated with favorable prognosis in patients with colorectal carcinomasLydia Brandl, David Horst, Enrico de Toni, et al.
The Journal of Pathology|July 22, 2009
The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancerDavid Horst, Silvio K Scheel, Sibylle Liebmann, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinomaMarkus Reschke, Ingvar Ferby, Ewa Stepniak, et al.
Cancer Research|February 17, 2017
Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS MutationsCristina Blaj, Eva Marina Schmidt, Sebastian Lamprecht, et al.
Nature Communications|November 12, 2017
Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancerSebastian Lamprecht, Eva Marina Schmidt, Cristina Blaj, et al.
Gastroenterology|August 13, 2018
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1Meryem Gülfem Öner, Matjaz Rokavec, Markus Kaller, et al.
BMC Cancer|November 3, 2019
Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapyIryna Trotsyuk, Halina Sparschuh, Alice Josephine Müller, et al.
Experimental and Molecular Pathology|November 22, 2011
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumorsTobias Vogler, Lydia Kriegl, David Horst, et al.
Pageof 23